BALTIMORE–(BUSINESS WIRE)–#fightcancer—Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with StanfordBALTIMORE–(BUSINESS WIRE)–#fightcancer—Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford

Kallisio Announces Clinical Implementation of Its Patient-Specific Stentra™ System

2025/12/23 00:32
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

BALTIMORE–(BUSINESS WIRE)–#fightcancer—Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford Health Care to support the clinical implementation of its FDA-cleared Stentra system for use in head and neck cancer radiation therapy.

Stentra is a patient-specific intraoral positioning system designed to support consistent immobilization during external beam radiation therapy. The system produces customized devices based on patient anatomy to assist with tongue and soft tissue positioning during treatment planning and daily radiation delivery.

As part of this collaboration, Stanford Health Care has incorporated Stentra into its clinical workflow for select head and neck cancer cases. The implementation reflects interest in evaluating tools that support reproducible setup and integration within existing radiation oncology processes.

Stentra is designed to be used during CT simulation and throughout the course of radiation therapy. Devices are manufactured using patient-specific digital workflows and are delivered for clinical use within standard treatment timelines. The system is intended to support geometric consistency during treatment while maintaining patient tolerance.

Kallisio’s broader clinical experience with Stentra across multiple institutions has focused on workflow integration, device reproducibility, and patient acceptance within routine radiation oncology operations.

About Kallisio

Kallisio develops patient-specific solutions designed to support precision radiation therapy. The company focuses on scalable, technology-enabled workflows that integrate digital design, manufacturing, and clinical processes to deliver individualized devices for oncology care. Kallisio works with clinical partners to evaluate and implement tools intended to support consistent treatment delivery and reduce variability in radiation therapy. Discover more at kallisio.com.

Contacts

Nicole E. Martin

nicole@kallisio.com
+1.415.860.9194

시장 기회
빔 로고
빔 가격(BEAM)
$0.01965
$0.01965$0.01965
+2.18%
USD
빔 (BEAM) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

Starter Gold Rush: Win $2,500!

Starter Gold Rush: Win $2,500!Starter Gold Rush: Win $2,500!

Start your first trade & capture every Alpha move